Houston Methodist
Houston Methodist's mission is to provide high quality, cost-effective health care that delivers the best value to the people we serve in a spiritual environment of caring in association with internationally recognized teaching and research.
For a full listing of current courses offering CME credit, visit learn.houstonmethodist.org
To access our ...
read more ↘
For a full listing of current courses offering CME credit, visit learn.houstonmethodist.org
To access our ...
read more ↘
Inaugural Bradley Z. Naifeh Amyloidosis Conference
Houston Methodist
FDA Perspective on New Therapies for Amyloidosis
FEATURING
Rosalyn Adigun
- 187 views
- April 14, 2023
- 2
Houston Methodist
Amyloidosis in the Neurology World: Neuropathies, Autonomic Dysfunction, and More
FEATURING
Sheetal Shroff
- 67 views
- April 14, 2023
- 1
Houston Methodist
Gastrointestinal Involvement and Management in Amyloidosis
FEATURING
Elizabeth Blaney
- 156 views
- April 14, 2023
- 1
Houston Methodist
Musculoskeletal Pathology as an Early Warning Sign of Systemic Amyloidosis
FEATURING
Shari Liberman
- 127 views
- April 14, 2023
- 2
Houston Methodist
Renal Involvement in Amyloidosis
FEATURING
Horacio Jose Adrogue
- 70 views
- April 14, 2023
- 1
Houston Methodist
Solid Organ Transplantation in Cardiac Amyloidosis
FEATURING
Arvind Bhimaraj
- 28 views
- April 14, 2023
Houston Methodist
Cardiac Case Presentation: 60 y/o Male With a History of Amyloidosis
- 76 views
- April 14, 2023
- 1
Houston Methodist
Amyloidosis: Pathophysiology
FEATURING
Siddhartha Ganguly
- 154 views
- April 14, 2023
- 2
Houston Methodist
Understanding AL Amyloidosis: Clinical Syndromes and Biological Implications
FEATURING
Vaishali Sanchorawala
- 56 views
- April 14, 2023
- 1
Houston Methodist
Recognizing TTR and Diagnostic Work-Up for Cardiac Amyloidosis
FEATURING
Barry Trachtenberg
- 62 views
- April 14, 2023
Houston Methodist
Current Treatment Options for AL Amyloidosis
FEATURING
Kelty Baker
- 183 views
- April 14, 2023
Houston Methodist
Novel Therapies in Amyloidosis: ATTT and Anti-Fibrils Strategies
FEATURING
Ashutosh Wechalekar
- 30 views
- April 14, 2023